Immunostimulation and host resistance against infection: therapeutic perspectives.
D000818:Animals; D000917:Antibody Formation; D001500:BCG Vaccine; D001419:Bacteria / Q000378:metabolism; D001424:Bacterial Infections / Q000276:immunology*; D004731:Endotoxins / Q000627:therapeutic use; D006168:Guinea Pigs; D006801:Humans; D007114:Immunization / Q000379:methods*; D007369:Interferon Inducers / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D008222:Lymphokines / Q000627:therapeutic use; D051379:Mice; D009161:Mycobacterium; D010743:Phospholipids / Q000276:immunology; D011425:Propionibacterium acnes; D051381:Rats; D013773:Tetramisole / Q000627:therapeutic use; D013935:Thymic Factor, Circulating / Q000627:therapeutic use; D014165:Transfer Factor / Q000627:therapeutic use; D014451:Ubiquinone / Q000627:therapeutic use
D001500:BCG Vaccine; D004731:Endotoxins; D007369:Interferon Inducers; D008222:Lymphokines; D010743:Phospholipids; D014165:Transfer Factor; D014451:Ubiquinone; D007978:Levamisole; D007372:Interferons; D013935:Thymic Factor, Circulating; D013773:Tetramisole